Clinical Trial Update: Bioequivalence Study of Ropinirole Hydrochloride CR 2mg Tablets of Lupin Limited, India, With REQUIP XL of GlaxoSmithKline Research Triangle Park, in Healthy, Adult, Male, Subjects Under Fed Conditions [Phase 1]

View source ↗

Summary

A Phase 1 bioequivalence study comparing Lupin's ropinirole hydrochloride CR 2 mg tablets to GlaxoSmithKline's REQUIP XL under fed conditions in healthy adult m…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease
• Restless Legs Syndrome

Drugs mentioned

• REQUIP XL (ropinirole)
• Ropinirole Hydrochloride CR 2 mg Tablets (Lupin Ltd.) (ropinirole hydrochloride)

Snippet

Sponsor: Lupin Ltd. | Conditions: Pharmacokinetic Study | Phase 1 | Status: COMPLETED